Cyclic controlled electrolysis apparatus

• US 4,846,950 A
• Filed: 09/10/1987
• Issued: 07/11/1989
• Est. Priority Date: 09/08/1983
• Status: Expired due to Term

• Current Assignee: Presbyterian University Hospital
• Original Assignee: Montefiore Hospital Association Of Western Pennsylvania
• Inventors: Wolfson, Sidney K. Jr., Yao, Shang J.
• Primary Examiner(s): Niebling, John F.
• Assistant Examiner(s): Marquis, Steven P.
• Application Number:
  US07/096,804
• Time in Patent Office: 670 Days
• Field of Search: 204/228, 204/231, 204/DIG. 9, 604/29, 604/20
• US Class Current: 204/229.2
• CPC Class Codes: A61M 1/1696 with dialysate regeneration

Abstract

Method and apparatus for cyclic control of both potential and current in electrolysis, called Cyclic, Controlled-potential, controlled current Electrolysis. The method can be used with a two-electrode cell (W and C), or a three-electrode set-up using a reference electrode R to form two half cells. The method involves supplying a controlled current, preferably a constant current, to the W and C electrodes to operate the electrolysis within well-defined upper and lower potential limits. In a first embodiment (called the constant-current, preset-voltage mode), when a predetermined voltage is reached, the current is reversed until a second predetermined voltage is reached. The cycle is then repeated continously. In a second embodiment (called the preset-voltage, preset-time mode) the current is maintained constant until the predetermined voltage is reached. Then the voltage is maintained constant by reducing the current until a predetermined time of operation has elapsed. Then the current is reversed and the cycle repeats. In the case of both embodiments, the cell operates as above for a preset period of time after which the preset voltage and/or cycle time control is switched with respect to W and C electrodes, the role of the electrodes thus alternating over a longer time period. By this cyclic electrolysis method, improved removal in hemodialysis or peritoneal dialysis of urea, uric acid, creatinine and other wastes is achieved. Better electrode surface regeneration, which occurs sequentially while electrolysis is continuous, is obtained. Production of undesirable or toxic substances such as chloramine, hypochlorite, nitrogen oxides, cyanide, ammonia, and the like are prevented. No electrode poisoning is observed. Both in vitro and also in vivo electrolysis is achieved by the method and apparatus of the invention. Physiologic electrolyte balance can be maintained.

Claims

1. Biomedical electrolysis apparatus for cyclic controlled current, controlled potential electroly tic oxidation of a metabolic waste comprising in operative combination:

(a) a continuous electrolysis cell having at least two continuously conductive electrodes including a working and a counter electrode, said cell being adapted for continuous flow therethrough, without disruption, of an aqueous media having said metabolic waste to be electrolyzed;

(b) means for providing a controlled current, i+ to i-, between said working electrode and said counter electrode in contact with said aqueous media having said metabolic waste substance;

(c) means for maintaining said controlled current i+ impressed on said electrodes for a period of time at least until a selected first voltage difference limit, V+, between said electrodes is achieved;

(d) means for sensing the potential difference in said cell between said electrodes measured as voltage, V+ or V-;

(e) means for sequentially cyclically reversing the direction of controlled current flow between said electrodes from i+ to i- in response to a predetermined voltage difference limit V+ or V- between said electrodes being sensed by said sensing means;

(f) means for reversing the operating voltage domain of said working and counter electrodes

(g) means for maintaining said reversed current i- impressed on said electrodes for a period of time at least until a selected second voltage difference limit, V-, between said electrodes is achieved; and

(h) means for cyclically continuing reversals of said currents i+ and i- between said limits of said selected voltages v+ and v- to continuously electrolytically oxidize at least portions of said metabolic waste substance.

2. Biomedical electrolysis apparatus as in claim 1 which includes:

(a) timer means for activating said voltage domain reversing means;

(b) means for reducing the current flow to said working and counter electrodes upon said preset voltage limit, V+ or V- , being exceeded to maintain said voltage substantially at said preset voltage difference limit prior to time elapsing for said cyclic reversal.

3. A biomedical electrolysis apparatus as in claim 2 which includes:

(a) a third electrode connected to said sensing means functioning as a reference electrode forming a first half cell in said media between said working electrode and said third electrode, and a second half cell between said counter electrode and said third electrode, said voltage differences V+ and V- being developed between said working and said reference electrodes.

4. A biomedical electrolysis apparatus as in claim 3 wherein:

(a) said cell is adapted for in vivo implantation.

5. A biomedical electrolysis apparatus as in claim 2 wherein:

(a) said cell is adapted for in vivo implantation.

6. A biomedical electrolysis appratus as in claim 2 wherein:

(a) both of said working and said counter electrodes are the same, one of said electrodes operating at least in part in a negative voltage domain and the other operating at least part in a positive voltage domain.

7. A biomedical electrolysis apparatus as in claim 2 wherein:

(a) said electrodes are selected from the group consisting of Pt-black, platinized titanium, rhodium black, palIadium black, gold, rhodium, platinum and palladium electrodes.

8. A biomedical electrolysis apparatus as in claim 1 which includes:

(a) a third electrode connected to said sensing means functioning as a reference electrode forming a first half cell in said media between said working electrode and said third electrode, and a second half cell between said counter electrode and said third electrode, said voltage differences V+ and V- being developed between said working and said reference electrodes.

9. A biomedical electrolysis apparatus as in claim 8 wherein:

(a) said cell is adapted for in vivo implantation

10. A biomedical electrolysis apparatus as in claim 1 wherein:

(a) said cell is adapted for in vivo implantation.

11. Biomedical electrolysis apparatus as in claim 1 wherein:

(a) said current providing means provides at least one of said currents i+ and i- as a constant current.

12. A biomedical electrolysis apparatus as in claim 11 wherein:

(a) said electrodes are selected from the group consisting of Pt-black, platinized titanium, rhodium black, palladium black, gold, rhodium, platinum and palladium electrodes.

13. A biomedical electrolysis apparatus as in claim 11 wherein:

(a) both of said working and said counter electrodes are the same, one of said electrodes operating at least in part in a negative voltage domain and the other operating at least part in a positive voltage domain.

14. A biomedical electrolysis apparatus as in claim 11 which includes:

(a) a third electrode connected to said sensing means functioning as a reference electrode forming a first half cell in said media between said working electrode and said third electrode, and a second half cell between said counter electrode and said third electrode, said voltage differences V+ and V- being developed between said working and said reference electrodes.

15. A biomedical electrolysis apparatus as in claim 14 wherein:

(a) said electrodes are selected from the group consisting of Pt-black, platinized titanium, rhodium black, palladium black, gold, rhodium, platinum and palladium electrodes.

16. A biomedical electrolysis apparatus as in claim 15 wherein:

(a) both of said working and said counter electrodes are the same, one of said electrodes operating at least in part in a negative voltage domain and the other operating at least in part in a positive voltage domain.

17. A biomedical electrolysis apparatus as in claim 15 wherein:

(a) said cell is adapted for in vivo implantation.

18. A biomedical electrolysis apparatus as in claim 1 wherein:

(a) said electrodes are selected from the group consisting of Pt-black, platinized titanium, rhodium black, palladium black, gold, rhodium, platinum and palladium electrodes.

19. A biomedical electrolysis apparatus as in claim 18 wherein:

(a) said cell is adapted for in vivo implantation.

20. A biomedical electrolysis apparatus as in claim 1 wherein:

(a) both of said working and said counter electrodes are the same, one of said electrodes operating at least in part in a negative voltage domain and the other operating at least part in a positive voltage domain.